OTRIVIN

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Finland, Hong Kong, Israel, Lithuania, Malta, Nigeria, Netherlands, New Zealand, Poland, Singapore, South Africa

Active ingredients

The drug OTRIVIN contains one active pharmaceutical ingredient (API):

1 Xylometazoline UNII X5S84033NZ - XYLOMETAZOLINE HYDROCHLORIDE

Xylometazoline acts directly on α-adrenoreceptors but does not act on β-receptors. When used topically as a nasal decongestant, xylometazoline acts rapidly and provides long-lasting relief. Onset of action is within minutes, the decongestant effect being prolonged and lasting for up to 10 hours. Read about Xylometazoline

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
OTRIVIN ADULT Menthol Nasal spray, solution	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R01AA07	Xylometazoline	R Respiratory system → R01 Nasal preparations → R01A Decongestants and other nasal preparations for topical use → R01AA Sympathomimetics, plain
Discover more medicines within R01AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00653330, 02208903, 02331403
Country: EE	Ravimiamet	Identifier(s): 1007020, 1007053, 1035975, 1035997
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 018176, 180539, 433136, 439794
Country: HK	Department of Health Drug Office	Identifier(s): 00187, 00195, 00219, 60243, 60495
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3995, 573, 574, 575, 576, 577, 578
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1007955, 1007956, 1015136, 1015614
Country: MT	Medicines Authority	Identifier(s): MA1177/00301, MA1177/00302, MA1177/00303, MA1177/00304, PI908/04005A
Country: NG	Registered Drug Product Database	Identifier(s): 04-0026, 04-5350
Country: NL	Z-Index G-Standaard	Identifier(s): 14708272, 14708280, 14708337
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 43311, 6661, 6688
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11729, 11730, 11731, 11732, 7834
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100108728, 100108740, 100108757, 100307132, 100379893, 100380152, 100386717, 100397253, 100407610, 100408028, 100413638, 100438868
Country: SG	Health Sciences Authority	Identifier(s): 11622P, 11623P, 11624P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/16.1/0319, H/16.1/1381, H/16.1/1382, J/16.1/311